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Intestinal colonization by bacteria of oral origin has been correlated with several negative health outcomes, including inflammatory bowel disease. However, a causal role of oral bacteria ectopically colonizing the intestine remains unclear. Using gnotobiotic techniques, we show that strains of Klebsiella spp. isolated from the salivary microbiota are strong inducers of T helper 1 (T H 1) cells when they colonize in the gut. These Klebsiella strains are resistant to multiple antibiotics, tend to colonize when the intestinal microbiota is dysbiotic, and elicit a severe gut inflammation in the context of a genetically susceptible host. Our findings suggest that the oral cavity may serve as a reservoir for potential intestinal pathobionts that can exacerbate intestinal disease.
T he average person generates and ingests 1.5 liters of saliva per day, containing an enormous number of oral-resident bacteria (1, 2) . Ingested oral bacteria poorly colonize the healthy intestine (3); however, increased levels of microbes of oral origin have been reported in the gut microbiota of patients with several diseases, including inflammatory bowel disease (IBD) (4), HIV infection (5, 6), liver cirrhosis (7, 8) , and colon cancer (9) . For instance, the presence of oral bacteria such as Veillonellaceae and Fusobacteriaceae in the intestinal mucosal microbiota strongly correlates with disease status in Crohn's disease (CD) (4) . Mining of our inhouse data sets of 16S ribosomal RNA (rRNA) gene sequences revealed that several bacterial taxa-including species belonging to Rothia, Streptococcus, Neisseria, Prevotella, and Gemella (table S1A), all of which are aerotolerant and typically members of the oral microbiota-were significantly more abundant in the fecal microbiota of patients with ulcerative colitis (UC), primary sclerosing cholangitis (PSC), gastroesophageal reflux disease (GERD) being treated by long-term proton pump inhibitor therapy, and alcoholism, compared with that of healthy controls ( Fig. 1A and table S1B). Thus, we hypothesized that a subset of oral microbiota may ectopically colonize and persist in the intestine under certain circumstances to aberrantly activate the intestinal immune system, resulting in chronic inflammatory diseases.
To search the human oral microbiota for bacterial strains showing strong immune-stimulatory activities upon intestinal colonization, we transplanted saliva samples from two patients with CD into C57BL/6 (B6) germ-free (GF) mice by gavage. Each group of mice was housed in separate gnotobiotic isolators for 6 weeks, at which time small intestinal and colonic lamina propria (LP) immune cells were examined. In mice receiving a saliva sample from CD patient #1 (GF+CD#1 mice), there were no significant changes in the intestinal T cells (Fig. 1B) . In contrast, in the group that received a saliva sample from CD patient #2 (GF+CD#2 mice), we noticed a marked accumulation of interferon-g + (IFN-g + ) CD4 + T cells [T helper 1 (T H 1) cells] in the intestinal LP (Fig. 1B) . Using 16S rRNA gene sequencing, we compared the community composition of the saliva microbiota before administration into GF mice and the fecal microbiota of the colonized animals (Fig. 1C) . Although the saliva samples of both patients contained similar microbial communities, the fecal microbiota compositions differed markedly between GF+CD#2 mice and GF+CD#1 mice (Fig. 1C) . Importantly, most of the bacterial species observed in the fecal microbiota of the mice had been minor components of the salivary microbiota (Fig. 1C) . These results indicate that bacterial species that constitute a small fraction of the oral microbiota can expand and colonize the gut, and a subset of these oral species can induce the accumulation of intestinal T H 1 cells.
To isolate T H 1 cell-inducing bacteria, we anaerobically cultured cecal contents from GF+CD#2 mice using several culture media and picked 224 colonies with different colony appearances. Sequencing of the 16S rRNA genes revealed that these colonies contained eight strains from diverse genera-including Gemella, Bifidobacterium, Streptococcus, Escherichia, Fusobacterium, Veillonella, Anaerococcus, and Klebsiella-and broadly represented the major members of the gut microbiota colonizing GF+CD#2 mice (Fig. 1C) . To examine whether these isolated strains had T H 1 cell-inducing capability, we cultured all eight of them and introduced them as a mixture (8-mix) into GF mice. We observed efficient induction of T H 1 cells in the colonic LP of these mice, with a magnitude comparable to that observed in GF+CD#2 mice (compare Fig. 1 , B and D). Because Fusobacterium and Veillonella have been implicated in IBD pathogenesis (4), we colonized mice with strains of these two genera (strain IDs Fu-21f and Ve-2E1, respectively); however, this resulted in only marginal elevation of T H 1 cell frequency (Fig. 1D) . We tested Klebsiella pneumoniae 2H7 (Kp-2H7) because it was the most prominent component of the GF+CD#2 microbiota (Fig. 1C) . Oral administration of Kp-2H7 alone significantly induced T H 1 cells, whereas a mixture of the remaining seven strains (7-mix) failed to do so (Fig. 1D) , indicating that the Kp-2H7 strain was the major contributor to the accumulation of T H 1 cells observed in GF+CD#2 mice. The effect of Kp-2H7 was relatively specific for T H 1 cells ( fig. S1A ), which were negative for interleukin-17 (IL-17), RORgt, and Foxp3 but positive for T-bet and CD44 ( fig. S1B ). Kp-2H7 mainly colonized the colon and cecum ( fig. S1C ), reflecting greater T H 1 cell induction in the colon than in the small intestine ( fig. S1D ). There was no increase in the percentage of T H 1 cells in the oral tissues (palate and tongue) of B6 GF+Kp-2H7 mice ( fig. S1E ). The increase in T H 1 cells was observed in IQI/Jic mice and B6 mice, but not in BALB/c mice ( fig. S1F ), implying interplay between host genotype and Kp-2H7 for colonic T H 1 cell induction.
Klebsiella spp. often acquire resistance to multiple antibiotics and can be a cause of health careassociated infection (10) (11) (12) . Our isolate Kp-2H7 was resistant to multiple antibiotics, including ampicillin (Amp), tylosin (Tyl), spectinomycin (Spc), and metronidazole (MNZ) ( fig. S2 ). Specificpathogen-free (SPF) mice were untreated or continuously treated with Amp, Tyl, Spc, or MNZ in drinking water starting 4 days before oral gavage with Kp-2H7. Antibiotic-naïve mice were resistant to colonization by Kp-2H7, but Amp or Tyl treatment allowed Kp-2H7 to persist in the intestine (Fig. 1E ). Persistent colonization with Kp-2H7 was accompanied by a significant increase in the frequency of colonic T H 1 cells (Fig. 1F ). In contrast to Amp and Tyl treatments, MNZ and Spc treatments did not allow Kp-2H7 colonization, although the Kp-2H7 strain is resistant to both of these antibiotics (Fig. 1E) . These results suggest that antibiotic exposure potentiates orally derived Kp-2H7 colonization by disrupting the colonization resistance provided by specific members of the gut microbiota that are Amp-and Tylsensitive but MNZ-and Spc-resistant. Despite induction of T H 1 cells, Kp-2H7 colonization did not induce any inflammatory changes in the intestine of wild-type (WT) hosts-either GF mice or Amp-treated SPF mice (Fig. 1, G to I,  and fig. S3, A and B) . Because microbial and host genetic factors both contribute to the pathogenesis of IBD (13), we tested the influence of Kp-2H7 colonization in colitis-prone Il10 -/-mice. GF WT and GF Il10 -/-mice were orally administered Kp-2H7, Escherichia coli 2B1 (Ec-2B1), or a mixture of the six other strains (6-mix). K. pneumoniae and E. coli are both in the family Enterobacteriaceae, which has been implicated in IBD pathogenesis (4, 14) . One week after colonization, more potent induction of colonic T H 1 cells was observed in Il10 -/-+Kp-2H7 mice than in the other groups Inner mucus layer B). These results suggest that Kp-2H7 acts as a gut pathobiont in the context of a genetically susceptible host. When Kp-2H7 was intratracheally injected into the lung, a T H 17 response predominated over a T H 1 response in lung T cells, consistent with previous reports (15, 16), and this response was accompanied by severe lung pathology, even in genetically normal mice ( fig. S4) . Therefore, the effect of Kp-2H7 on T H 1 induction appears to be a gut-specific response.
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To investigate the mechanism of Kp-2H7-mediated T H 1 cell induction, we orally administered heat-killed Kp-2H7 to GF WT B6 mice in drinking water for 3 weeks. Heat-killed bacteria had no effect on the frequency of T H 1 cells (Fig. 2A) . evidence of adhesion or invasion of bacteria on or into the epithelial layer (Fig. 2B) . Phylogenetically distinct human, mouse, and environmental K. pneumoniae strains ( fig. S5A and table S2 ) showed considerable variability in the ability to elicit colonic T H 1 cell induction when monocolonized in B6 WT mice (Fig. 2C) . In particular, KCTC2242 and BAA2552 did not affect, or only weakly affected, T H 1 cell frequency. The intensity of induction was independent of bacterial load and was not accompanied by inflammation ( fig. S5B ). There was no correlation between T H 1 cell induction and multilocus sequence typing, K-typing, or phylogeny ( fig. S5A and table S2 ). Comparative analysis of the whole genomes revealed that 61 orthologous groups of genes were positively correlated with the T H 1 induction ability, including genes predicted to encode hemolysin-coregulated protein (Hcp) and enzymes involved in fructose-, galactitol-, mannose-, and long-chain fatty acidrelated uptake and metabolic pathways (Fig. 2D  and table S3 ). These genes have been reported to be enriched in the fecal microbiome of patients with inflammatory diseases and have been suggested to have immunomodulatory effects, and they thereby may contribute to the induction of T H 1 cells (8, 14, (17) (18) (19) . Mice deficient in basic leucine zipper transcription factor ATF-like 3 (Batf3 -/-), which lack the intestinal CD11b -
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+ dendritic cell (DC) subset, failed to mount a colonic T H 1 cell response (Fig. 2E) . Assessment of the antigen specificity of colonic T H 1 cells induced by Kp-2H7 revealed that a substantial fraction recognized Klebsiella antigens ( fig. S6 ), including OmpX (outer membrane protein X) (20). Colonic T H 1 induction by Kp-2H7 monocolonization was significantly suppressed in Myd88 -/-and Myd88 -/-Trif -/-mice and partially attenuated in Tlr4 -/-mice and Il18 -/-mice, but occurred normally in Il1r1 -/-mice (Fig. 2, F and G) . Increased production of IL-18 by colonic epithelial cells (ECs) was detected after monocolonization with Kp-2H7 ( fig. S6B) . Together, these results suggest contributions from Toll-like receptors (TLRs) and IL-18 signaling to the DC-mediated Klebsiella antigen-specific T H 1 cell induction.
RNA-sequencing (RNA-seq) data for colonic ECs and CD11c + DCs isolated from WT mice monocolonized with Kp-2H7 or BAA2552 for 1 week, and from WT, Myd88
, and Tlr4
-/-mice monocolonized with Kp-2H7 for 3 weeks, were compared with data for GF mice (Fig. 2H and figs. S7 and S8) . IFN-inducible (IFI) genes-such as those encoding guanylate-binding proteins (GBPs), chemokine (C-X-C motif) ligand 9 (Cxcl9), major histocompatibility complex-related molecules (MHCs; e.g., H2-DMb1, H2-Ab1, and Tap1), and dual oxidase 2 (Duox2)-were significantly up-regulated in colonic ECs and DCs from GF WT+Kp-2H7 mice. Expression differences were confirmed by quantitative polymerase chain reaction (qPCR) analysis (fig. S9A) . The up-regulation of IFI genes in colonic ECs of GF+Kp-2H7 mice began within 3 days of colonization ( fig. S9B ), when T H 1 induction was limited ( fig. S9C ). Bacteriafree cecal suspensions from GF+Kp-2H7 mice upregulated IFI genes in a colonic EC line in vitro ( fig. S10 ), suggesting direct effects of bacterial products on the induction of IFI genes. In the later phase of Kp-2H7 colonization, IFI genes were further up-regulated, coinciding with the increase of T H 1 cells ( fig. S9 , A to C). GBPs are known to function as microbial receptors (21) . MHCs and Cxcl9 mediate development and recruitment of T H 1 cells. Duox2 mediates production of hydrogen peroxide, which may facilitate further colonization of reactive oxygen-tolerant Klebsiella spp. (22, 23) . IFN-g receptor 1-deficient (IFNgR1 -/-) mice mounted a defective T H 1 cell response upon colonization with Kp-2H7 (Fig. 2I) . These results suggest that a feedforward loop involving IFN-g and IFIs was created among ECs, DCs, and T cells for sustained accumulation of T H 1 cells.
To confirm the link between oral-derived bacteria and T H 1 cell induction, we obtained additional saliva samples from two healthy donors (He#1 and He#2) and two patients with active UC (UC#1 and UC#2) and orally administered these samples to GF WT B6 mice. T H 1 cells accumulated in the colonic LP of mice inoculated with a saliva sample from UC patient #2 (GF+UC#2 mice), comparably to the accumulation observed in GF+CD#2 mice (Fig. 3A) . We cultured cecal contents from GF+UC#2 mice and isolated 13 strains, which resembled the microbiota composition of GF+UC#2 mice (Fig. 3B) . Oral administration of the 13 strains (13-mix) into GF mice fully replicated the phenotype observed in GF+UC#2 mice in terms of colonic T H 1 cell induction (Fig. 3C) . Among the 13 strains, Enterococcus faecium 11A1 (Ef-11A1) and Klebsiella aeromobilis 11E12 (Ka-11E12) drew our attention, because both species have been implicated in IBD pathogenesis and reported to be important multidrug-resistant pathobionts (24) (25) (26) (27) . GF mice were gavaged either with Ef-11A1, Ka-11E12, or a mixture of the 11 other strains (11-mix). Ka-11E12 induced T H 1 cells in the colon comparably to the 13-mix, whereas Ef-11A1 and the 11-mix failed to do so (Fig. 3C) . Therefore, Ka-11E12 was most likely the major driver for the induction of T H 1 cells observed in GF+UC#2 mice, even as a minor member of the gut microbiota (Fig. 3B) . Ka-11E12 was also resistant to multiple antibiotics (fig. S11, A and B) and persisted in the intestine of vancomycin-or Tyl-treated SPF mice (Fig. 3D) . Ka-11E12 colonization resulted in severe inflammation in Il10 -/-mice (fig. S11, C and D, and Fig. 3E ), suggesting that the orally derived K. aeromobilis strain may act similarly to Kp-2H7. Likewise, Ka-11E12 did not attach to the EC surface, as shown by FISH (Fig. 3F) . However, genome sequence analysis and electron microscopy (EM) revealed that, in contrast to Kp-2H7, Ka-11E12 had a flagellar assembly system (table S4 and fig. S12A ) and was highly motile and stimulatory for TLR5 ( fig. S12 , B and C). Therefore, distinct mechanisms may drive T H 1 cell induction by different Klebsiella strains.
Somewhat unexpectedly, the microbiota sample from one healthy donor (He#1) also induced a substantial increase in T H 1 cells (Fig. 3A) . In this case, the fecal microbiome contained a K. pneumoniae sequence. We isolated a K. pneumoniae strain, Kp-40B3 (Fig. 3B) . This strain induced marked T H 1 cell accumulation in the colon of monocolonized mice (Fig. 3G) . Whole-genome sequence analysis revealed that Kp-40B3 possessed several genes that correlated with Kp-2H7-mediated T H 1 cell induction (Fig. 2D) . These results suggest that Klebsiella spp. with T H 1 cell induction capability may exist in the oral cavity of not only IBD patients but also healthy humans.
We mined the 16S rRNA gene-sequencing data sets used in the analysis in Fig. 1A and found that the relative abundance of members of Klebsiella was significantly higher in patients with CD (P = 0.0157), PSC (P = 0.0309), and alcoholism (P < 0.0001) compared with that in healthy controls (Fig. 4A) . We extended our analysis to the metagenome databases of intestinal microbiota of IBD patients and non-IBD controls from the Prospective Registry in IBD Study at Massachusetts General Hospital (PRISM) (14) and the CD cohort from the University of Pennsylvania (UPenn cohort) (28) . The aggregated relative abundance of Klebsiella species was significantly higher in patients with IBD (P < 0.01) (Fig. 4B) . The genes that were correlated with Kp-2H7-mediated T H 1 induction (shown in Fig. 2D ) were enriched in the fecal microbiome of IBD patients who carried Klebsiella species, but not in non-IBD individuals (Fig. 4 , C and D; P = 0.00988, Mann-Whitney U test).
Ectopic colonization of the colon by orally derived Klebsiella spp. is associated with aberrant activation of the immune system. The lower gastrointestinal tract is the expected niche for Klebsiella spp., where they constitute a minor population that can proliferate after antibiotic treatment and other conditions (24) . Our data suggest that the oral cavity may serve as another reservoir for Klebsiella pathobionts. Indeed, the oral microbiota contains the highest relative abundance of Enterobacteriaceae compared with other mucosal sites (29) . The inflammatory state in IBD may render the intestine more permissive to aerotolerant oral-derived bacteria than the steady-state intestine, and ongoing colonization by oral bacteria may help perpetuate gut microbiota dysbiosis and chronic inflammation. Overrepresentation of Klebsiella spp. in the gut microbiota, coupled with elevated levels of serum antibodies against Klebsiella antigens, has been reported in patients with IBD (30, 31) . In mouse models of IBD, such as T-bet -/-
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-/-mice, K. pneumoniae is known to proliferate and play an important role in triggering disease (32) . Furthermore, persistence of Klebsiella spp. is also observed in several other diseases (Fig. 4A) (33) . Thus, our findings indicate that targeting oralderived bacteria, particularly Klebsiella, could provide a therapeutic strategy to correct IBD and many other disease conditions.
Our results highlight the disease potential of antibiotic-resistant, proinflammatory Klebsiella in chronic human disease. K. pneumoniae and K. aeromobilis commonly cause hospital infections (10-12, 24, 25) . Our isolates were resistant to several antibiotics, and treatment with antibiotics allowed their colonization in the intestine of SPF mice. The colonization efficiency of Kp-2H7 and Ka-11E12 varied, depending on the spectrum of antibiotics used as treatment. Therefore, identifying members of the normal gut microbiota that can provide colonization resistance against orally derived bacteria could foster future avenues for the development of effective treatments for multidrug-resistant bacteria and chronic inflammation.
